Our ARC EM Director, Professor Kamlesh Khunti, is based at the Leicester Diabetes Centre and is also a part of an international panel of experts providing recommendations for the management of diabetes in patients with COVID-19.
This is because diabetes is one of the most important comorbidities linked to the severity of all three known human pathogenic coronavirus infections, including severe acute respiratory syndrome coronavirus.
Patients with diabetes have an increased risk of severe complications including Adult Respiratory Distress Syndrome and multi-organ failure. Depending on the global region, 20–50% of patients in the coronavirus disease 2019 (COVID-19) pandemic had diabetes. Given the importance of the link between COVID-19 and diabetes, an international panel of experts have been formed in the field of diabetes and endocrinology to provide some guidance and practical recommendations for the management of diabetes during the pandemic.
A recent paper aims to briefly provide insight into potential mechanistic links between the novel coronavirus infection and diabetes, present practical management recommendations, and elaborate on the differential needs of several patient groups.
Bornstein, S.R., Rubino, F., Khunti, K., Mingrone, G., Hopkins, D., Birkenfeld, A.L., Boehm, B., Amiel, S., Holt, R.I., Skyler, J.S. and DeVries, J.H., 2020. Practical recommendations for the management of diabetes in patients with COVID-19. The Lancet Diabetes & Endocrinology.
Access the publication here: https://doi.org/10.1016/S2213-8587(20)30152-2